Professor, Atlantic Veterinary College, University of Prince Edward Island
For decades marine culture of Atlantic salmon has been hampered by sea lice, namely Lepeophtheirus salmonis in the Northern Hemisphere and Caligus rogercresseyi in the Southern Hemisphere. In the face of reduced efficacy of anti-parasitic treatments due to resistance, the industry has focused on different intervention strategies. These new strategies in turn have been supported by and driven changes in research focus. In the midst of declining use of medicinal intervention; mechanical treatments, freshwater baths, biological control and genetic improvements to salmon have been at the forefront of the industry’s response. Subsequent impacts on fish welfare, behaviour, potential selection pressures and methods for inducing effective host responses to infection have been the focus of our research to support these industry trends. This seminar will discuss the multi-pronged research approach to addressing these gaps in disease management, and providing applied solutions to these issues.
Dr. Mark Fast is a professor of fish health and comparative immunology at the Atlantic Veterinary College at the University of Prince Edward Island, Canada. His research group (Hoplite Research lab; The Hoplite lab | Hoplite Lab) investigates how the environment impacts host-pathogen relationships using genomic techniques, in particular with respect to how this affects cultured species such as salmon. For over 20 years, Dr. Fast’s research group has focused on the host-parasite relationship of sea lice and salmon such as CRISPResist, GenoLice, and LiceResist. Since his post doctoral fellowship at the Institute for Marine Bioscience, he has also been involved in vaccine development (patenting multiple vaccines for salmon), and most recently investigating the application of mRNA vaccine technology to salmonid diseases.